These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34746709)

  • 1. IL-1beta promotes the age-associated decline of beta cell function.
    Böni-Schnetzler M; Méreau H; Rachid L; Wiedemann SJ; Schulze F; Trimigliozzi K; Meier DT; Donath MY
    iScience; 2021 Nov; 24(11):103250. PubMed ID: 34746709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion.
    Böni-Schnetzler M; Häuselmann SP; Dalmas E; Meier DT; Thienel C; Traub S; Schulze F; Steiger L; Dror E; Martin P; Herrera PL; Gabay C; Donath MY
    Cell Rep; 2018 Feb; 22(7):1774-1786. PubMed ID: 29444430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets.
    Hui Q; Asadi A; Park YJ; Kieffer TJ; Ao Z; Warnock GL; Marzban L
    Mol Metab; 2017 Aug; 6(8):833-844. PubMed ID: 28752047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6.
    Nackiewicz D; Dan M; He W; Kim R; Salmi A; Rütti S; Westwell-Roper C; Cunningham A; Speck M; Schuster-Klein C; Guardiola B; Maedler K; Ehses JA
    Diabetologia; 2014 Aug; 57(8):1645-54. PubMed ID: 24816367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid formation reduces protein kinase B phosphorylation in primary islet β-cells which is improved by blocking IL-1β signaling.
    Zhang Y; Warnock GL; Ao Z; Park YJ; Safikhan N; Ghahary A; Marzban L
    PLoS One; 2018; 13(2):e0193184. PubMed ID: 29474443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I.
    Böni-Schnetzler M; Boller S; Debray S; Bouzakri K; Meier DT; Prazak R; Kerr-Conte J; Pattou F; Ehses JA; Schuit FC; Donath MY
    Endocrinology; 2009 Dec; 150(12):5218-29. PubMed ID: 19819943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
    Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
    Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin.
    Duvillié B; Currie C; Chrones T; Bucchini D; Jami J; Joshi RL; Hill DJ
    Endocrinology; 2002 Apr; 143(4):1530-7. PubMed ID: 11897712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2, not microsomal prostaglandin E synthase-1, is the mechanism for interleukin-1β-induced prostaglandin E2 production and inhibition of insulin secretion in pancreatic islets.
    Parazzoli S; Harmon JS; Vallerie SN; Zhang T; Zhou H; Robertson RP
    J Biol Chem; 2012 Sep; 287(38):32246-53. PubMed ID: 22822059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat.
    Ehses JA; Lacraz G; Giroix MH; Schmidlin F; Coulaud J; Kassis N; Irminger JC; Kergoat M; Portha B; Homo-Delarche F; Donath MY
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13998-4003. PubMed ID: 19666548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets.
    Téllez N; Montolio M; Biarnés M; Castaño E; Soler J; Montanya E
    Gene Ther; 2005 Jan; 12(2):120-8. PubMed ID: 15578044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?
    Welsh N; Cnop M; Kharroubi I; Bugliani M; Lupi R; Marchetti P; Eizirik DL
    Diabetes; 2005 Nov; 54(11):3238-44. PubMed ID: 16249450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.
    Maedler K; Sergeev P; Ris F; Oberholzer J; Joller-Jemelka HI; Spinas GA; Kaiser N; Halban PA; Donath MY
    J Clin Invest; 2002 Sep; 110(6):851-60. PubMed ID: 12235117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets.
    Maedler K; Schumann DM; Sauter N; Ellingsgaard H; Bosco D; Baertschiger R; Iwakura Y; Oberholzer J; Wollheim CB; Gauthier BR; Donath MY
    Diabetes; 2006 Oct; 55(10):2713-22. PubMed ID: 17003335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
    Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
    Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of miR-153, an IL-1β-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.
    Sun Y; Zhou S; Shi Y; Zhou Y; Zhang Y; Liu K; Zhu Y; Han X
    Metabolism; 2020 Oct; 111():154335. PubMed ID: 32795559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets.
    Maedler K; Størling J; Sturis J; Zuellig RA; Spinas GA; Arkhammar PO; Mandrup-Poulsen T; Donath MY
    Diabetes; 2004 Jul; 53(7):1706-13. PubMed ID: 15220194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.
    Böni-Schnetzler M; Thorne J; Parnaud G; Marselli L; Ehses JA; Kerr-Conte J; Pattou F; Halban PA; Weir GC; Donath MY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4065-74. PubMed ID: 18664535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.